Timo Minssen

Timo Minssen

Professor

ORCID: 0000-0002-3286-4888

Publication year:
All
31 - 40 out of 225Page size: 10
Sort by: 1st author
  1. Published

    A qualitative study of biosimilar manufacturer and regulator perceptions on intellectual property and abbreviated approval pathways

    Druedahl, Louise C., Almarsdóttir, Anna Birna, Kälvemark Sporrong, Sofia, De Bruin, M. L., Hoogland, H., Minssen, Timo, van de Weert, Marco, Kesselheim, A. S. & Sarpatwari, A., 2020, In: Nature Biotechnology. 38, 11, p. 1253-1256 4 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  2. Published

    Evolving biosimilar clinical requirements: A qualitative interview study with industry experts and European national medicines agency regulators

    Druedahl, Louise C., Kälvemark Sporrong, Sofia, van de Weert, Marco, De Bruin, M. L. (., Hoogland, H., Minssen, Timo & Almarsdóttir, Anna Birna, 2021, In: BioDrugs. 35, p. 351-361

    Research output: Contribution to journal › Journal article › Research › peer-review

  3. Published

    Collaboration in Times of Crisis: A Study on COVID-19 Vaccine R&D Partnerships

    Druedahl, Louise C., Minssen, Timo & Price II, W. N., 8 Oct 2021, In: Vaccine. 39, 42, p. 6291 - 6295

    Research output: Contribution to journal › Journal article › Research › peer-review

  4. Published

    Interchangeability of biosimilars: A study of expert views and visions regarding the science and substitution

    Druedahl, Louise C., Kälvemark Sporrong, Sofia, Minssen, Timo, Hoogland, H., De Bruin, M. L. (., van de Weert, Marco & Almarsdóttir, Anna Birna, 2022, In: PLOS One. 17, 1, p. 1-13 13 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  5. Published

    Medicines authority regulators and industry perspectives on the European regulation of biosimilars

    Druedahl, Louise C., De Bruin, M. L. (., van de Weert, Marco, Minssen, Timo, Hoogland, H. & Almarsdóttir, Anna Birna, 2019.

    Research output: Contribution to conference › Conference abstract for conference › Research › peer-review

  6. Submitted

    The Use of Artificial Intelligence in Drug Development: A Cross-Sectional Study

    Druedahl, Louise C., Price II, W. N., Minssen, Timo & Sarpatwari, A., Jan 2024, (Submitted) In: JAMA network open.

    Research output: Contribution to journal › Journal article › Research › peer-review

  7. Published

    MEDICINES AUTHORITY REGULATOR AND INDUSTRY PERCEPTIONS OF BIOSIMILAR INTERCHANGEABILITY

    Druedahl, Louise C., De Bruin, M. L., Hoogland, H., Minssen, Timo, van de Weert, Marco, Kälvemark Sporrong, Sofia & Almarsdóttir, Anna Birna, Dec 2019, p. E45-E46.

    Research output: Contribution to conference › Conference abstract for conference › Research › peer-review

  8. Published

    ELSI Implications of Prioritizing Biological Therapies in the Times of COVID-19

    Druedahl, Louise C., Lebret, Audrey & Minssen, Timo, Oct 2020, In: Journal of Law, Medicine & Ethics. 48, 3, p. 579-582

    Research output: Contribution to journal › Journal article › Research › peer-review

  9. Published

    Germany’s Digital Health Reforms in the COVID-19 Era: Lessons and Opportunities for Other Countries

    Gerke, S., Stern, A. & Minssen, Timo, 10 Jul 2020, In: Nature PJ Digital Medicine. 3, p. 1-6 6 p., 94.

    Research output: Contribution to journal › Journal article › Research › peer-review

  10. Published

    Ethical and legal issues of ingestible electronic sensors

    Gerke, S., Minssen, Timo, Yu, H. & Cohen, G., 15 Aug 2019, In: Nature Electronics . 2, 8, p. 329–334 5 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

Previous 1 2 3 4 5 6 7 8 ...23 Next

ID: 16150437